Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital

British Journal of Clinical Pharmacology

Volumn 60, Issue 6, 2005, Pages 653-658

  Vallano, Antonio ^a,b,c,d   Cereza, G ^a,d   Pedros C ^a,d   Agusti A ^a,b,c   Danes I ^a   Aguilera, C ^a,b,c   Arnau, J M ^a,b,c  

^a Fundacion Institut Catala de Farmacologia   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d Catalan Centre of Pharmacovigilance   (Spain)

Author keywords

Adverse drug reaction; Adverse drug reaction reporting systems; Attitude; Communication barriers; Hospital; Pharmacovigilance

Indexed keywords

ARTICLE; DRUG SURVEILLANCE PROGRAM; FEEDBACK SYSTEM; HEALTH CARE; HUMAN; MEDICAL INFORMATICS; MEDICAL PRACTICE; MEDICAL SPECIALIST; NORMAL HUMAN; OBSERVER VARIATION; PERCEPTION; PHYSICIAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; SUPPORT GROUP; WORKLOAD;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ATTITUDE OF HEALTH PERSONNEL; COMMUNICATION; CONFLICT OF INTEREST; FEEDBACK; FOCUS GROUPS; HOSPITALS, TEACHING; HUMANS; MEDICAL STAFF, HOSPITAL; PHARMACEUTICAL PREPARATIONS; RISK MANAGEMENT; SPAIN; WORKLOAD;

EID: 28244501838     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2005.02504.x     Document Type: Article

References (19)

1. Routledge P. 150 years of pharmacovigilance. Lancet 1998; 351 : 1200-1.
2. Wiholm BE, Olsson S, Moore N, Waller P. Spontaneous reporting systems outside the United States. In Pharmacoepidemiology, 3rd edn, ed. Strom BL. Chichester: Wiley 2000; 175-92.
3. Inman WHW, Weber JCP. The United Kingdom. In Monitoring for Drug Safety, 2nd edn, ed. Inman WHW, Lancaster: MTP Press 1986; 13-47.
4. Bateman DN, Sanders GL, Rawlins MD. Attitudes to ADR reporting in the Northern Region. Br J Clin Pharmacol 1992; 34: 421-6.
5. Belton KJ, Lewis SC, Payne S, Rawlins MD, Wood SM. Attitudinal survey of ADR reporting by medical practitioners in the United Kingdom. Br J Clin Pharmacol 1995; 39: 223-6.
6. Rawlins MD. Pharmacovigilance; paradise lost, regained or postponed?. The William Withering Lecture 1994. J R Coll Physicians Lond 1995; 29: 41-9.
7. Mays N, Pope C. Rigour and qualitative research. BMJ 1995; 311 : 109-12.
8. Kitzinger J. Qualitative research. Introducing focus groups. BMJ 1995; 311: 299-302.
9. Anonymous. Commission Directive 2000/38/EC of 5 June 2000 amending Chapter Va (Pharmacovigilance) of Council Directive 75/319/EEC on the approximation of provisions laid down by law, regulation or administrative action relating to medicinal products.
10. Anonymous. Royal Decree 711/2002, of 19 July 2002, regulating Pharmacovigilance of medicinal products for human use in Spain.
11. McGettigan P, Feely J. ADR reporting: opinions and attitudes of medical practitioners in Ireland. Pharmacoepidemiol Drug Saf 1995; 4: 355-8.
12. Belton KJ. Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. The European Pharmacovigilance Research Group. Eur J Clin Pharmacol 1997; 52: 423-7.
13. McGettigan P, Golden J, Conroy RM, Arthur N, Feely J. Reporting of ADR by hospital doctors and the response to intervention. Br J Clin Pharmacol 1997; 44: 98-100.
14. Eland IA, Belton KJ, van Grootheest AC, Meiners AP, Rawlins MD, Stricker BH. Attitudinal survey of voluntary reporting of ADR. Br J Clin Pharmacol 1999; 48: 623-7.
15. Bäckström M, Mjorndal T, Dahlqvist R, Nordkvist-Olsson T. Attitudes to reporting ADR in northern Sweden. Eur J Clin Pharmacol 2000; 56: 729-32.
16. Figueiras A, Tato F, Fontainas J, Takkouche B, Gestal-Otero JJ. Physicians' attitudes towards voluntary reporting of adverse drug events. J Eval Clin Pract 2001; 7: 347-54.
17. Hasford J, Goettler M, Munter KH, Muller-Oerlinghausen B. Physicians' knowledge and attitudes regarding the spontaneous reporting system for ADR. J Clin Epidemiol 2002; 55: 945-50.
18. Biriell C, Edwards IR. Reasons for reporting ADR - some thoughts based on an international review. Pharmacoepidemiol Drug Saf 1997; 6: 21-6.
19. Anonymous. Improved ADR Reporting: Report from working groups at the twenty-sixth annual meeting of National Centres, WHO International Drug Monitoring Programme, 8-10 December 2003. WHO Pharmaceuticals Newsletter 2004; 2: 6.